An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus

被引:386
作者
James, JA
Kaufman, KM
Farris, AD
Taylor-Albert, E
Lehman, TJA
Harley, JB
机构
[1] Univ Oklahoma, Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA
[2] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK 73104 USA
[3] Dept Vet Affairs Med Ctr, Oklahoma City, OK 73104 USA
[4] Hosp Special Surg, New York, NY 10021 USA
关键词
autoimmunity; autoantibodies; viral infection; autoimmune disease; SLE;
D O I
10.1172/JCI119856
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
An unknown environmental agent has been suspected to induce systemic lupus erythematosus (lupus) in man. Prompted by our recent immunochemical findings, we sought evidence for an association between Epstein-Barr virus infection and lupus. Because the vast majority of adults have been infected with Epstein-Barr virus, we chose to study children and young adults, Virtually all (116 of 117, or 99%) of these young patients had seroconverted against Epstein-Barr virus, as compared with only 70% (107 of 153) of their controls (odds ratio 49.9, 95% confidence interval 9.3-1025, P < 0.00000000001). The difference in the rate of Epstein-Barr virus seroconversion could not be explained by serum IgG level or by cross-reacting anti-Sm/nRNP autoantibodies. No similar difference was found in the seroconversion rates against four other herpes viruses, An assay for Epstein-Barr viral DNA in peripheral blood lymphocytes established Epstein-Parr virus infection in the peripheral blood of all 32 of the lupus patients tested, while only 23 of the 32 matched controls were infected (odds ratio > 10, 95% confidence interval 2.53-infinity, P < 0.002), When considered with other evidence supporting a relationship between Epstein-Barr virus and lupus, these data are consistent with, but do not in themselves establish, Epstein-Barr virus infection as an etiologic factor in lupus.
引用
收藏
页码:3019 / 3026
页数:8
相关论文
共 36 条
[11]   DETECTION OF ANTIBODIES TO THE EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS IN THE SERA FROM PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
KITAGAWA, H ;
IHO, S ;
YOKOCHI, T ;
HOSHINO, T .
IMMUNOLOGY LETTERS, 1988, 17 (03) :249-252
[12]  
KLIPPLE JH, 1973, LANCET, V1, P1057
[13]   2 SMALL RNAS ENCODED BY EPSTEIN-BARR VIRUS AND COMPLEXED WITH PROTEIN ARE PRECIPITATED BY ANTIBODIES FROM PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
LERNER, MR ;
ANDREWS, NC ;
MILLER, G ;
STEITZ, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (02) :805-809
[14]   INHIBITION OF ANTIGEN-PROCESSING BY THE INTERNAL REPEAT REGION OF THE EPSTEIN-BARR-VIRUS NUCLEAR ANTIGEN-1 [J].
LEVITSKAYA, J ;
CORAM, M ;
LEVITSKY, V ;
IMREH, S ;
STEIGERWALDMULLEN, PM ;
KLEIN, G ;
KURILLA, MG ;
MASUCCI, MG .
NATURE, 1995, 375 (6533) :685-688
[15]  
MALEFYT RD, 1991, J EXP MED, V178, P439
[16]   IMMUNE-RESPONSE TO DIFFERENT SEQUENCES OF THE EBNA-I MOLECULE IN EPSTEIN-BARR VIRUS-RELATED DISORDERS AND IN AUTOIMMUNE-DISEASES [J].
MARCHINI, B ;
DOLCHER, MP ;
SABBATINI, A ;
KLEIN, G ;
MIGLIORINI, P .
JOURNAL OF AUTOIMMUNITY, 1994, 7 (02) :179-191
[17]   A NOVEL FORM OF EPSTEIN-BARR-VIRUS LATENCY IN NORMAL B-CELLS IN-VIVO [J].
MIYASHITA, EM ;
YANG, B ;
LAM, KMC ;
CRAWFORD, DH ;
THORLEYLAWSON, DA .
CELL, 1995, 80 (04) :593-601
[18]   VIRAL INTERLEUKIN-10 IS CRITICAL FOR THE INDUCTION OF B-CELL GROWTH TRANSFORMATION BY EPSTEIN-BARR-VIRUS [J].
MIYAZAKI, I ;
CHEUNG, RK ;
DOSCH, HM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (02) :439-447
[19]   ANTIBODIES AGAINST POLYPEPTIDES OF PURIFIED EPSTEIN-BARR-VIRUS IN SERA FROM PATIENTS WITH CONNECTIVE-TISSUE DISEASES [J].
NGOU, J ;
GRAAFLAND, H ;
SEGONDY, M .
JOURNAL OF AUTOIMMUNITY, 1992, 5 (02) :243-249
[20]   ANTIBODY-RESPONSES AGAINST POLYPEPTIDE COMPONENTS OF EPSTEIN-BARR VIRUS-INDUCED EARLY DIFFUSE ANTIGEN IN PATIENTS WITH CONNECTIVE-TISSUE DISEASES [J].
NGOU, J ;
SEGONDY, M ;
SEIGNEURIN, JM ;
GRAAFLAND, H .
JOURNAL OF MEDICAL VIROLOGY, 1990, 32 (01) :39-46